Skip to main content
Nichole Tucker on Muck Rack

Nichole Tucker

Verified
(She/Her)
Atlanta
As seen in: Blood Cancers Today, Patch, Inquisitr, Paste, Lifehack!, NewsBreak, The Mighty, American Journal of Managed Care, ONCOLOGY journal, CURE Magazine, OncLive and
Covers:  Healthcare Pharmaceuticals Biotechnology/Medical Devices Integrative Medicine Health Commerce Health Policy Community Medicine Rural Health Urban Health
Medical Journalist

Get in touch with Nichole

Contact Nichole, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Nichole Tucker’s Biography

Read Full Bio →

Editorial leader, writer/editor, and master content strategist.

Nichole Tucker’s Journalist Portfolio

See all →
What Does CLL Treatment Without the Infusion Chair Mean for Clinics and Patients? | Blood Cancers...

What Does CLL Treatment Without the Infusion Chair Mean for Clinics and Patients? | Blood Cancers...

The all-oral, fixed-duration regimen acalabrutinib plus venetoclax enters the treatment paradigm for patients…

View article →
Rapcabtagene Autoleucel Delivers Promising First Line Outcomes in High Risk LBCL | Blood Cancers ...

Rapcabtagene Autoleucel Delivers Promising First Line Outcomes in High Risk LBCL | Blood Cancers ...

At the Tandem Meetings held in Salt Lake City, UT is March 2026, clinical investigators reported phase 2 clin…

View article →
Oncology Drug Shortages Persist, Calling for Solutions

Oncology Drug Shortages Persist, Calling for Solutions

With a growing number of chemotherapy agents currently unavailable for patients with solid tumors and hematol…

View article →
The Fellowship Forging Tomorrow's Hematology Experts | Blood Cancers Today

The Fellowship Forging Tomorrow's Hematology Experts | Blood Cancers Today

In Rochester, MN, Mayo Clinic is home to one of the more prestigious fellowship programs for doctors in train…

View article →
Personalized Antiemetic Strategies Redefine Supportive Care in Chemotherapy | Blood Cancers Today

Personalized Antiemetic Strategies Redefine Supportive Care in Chemotherapy | Blood Cancers Today

The need for personalized, risk-adapted antiemetic chemotherapy strategies for patients has been reinforced …

View article →
FDA's ODAC Votes Yes to Requiring Randomized Data for Future PI3Ki Approvals in Hematologic Cance...

FDA's ODAC Votes Yes to Requiring Randomized Data for Future PI3Ki Approvals in Hematologic Cance...

In a 16 to 0 vote, the FDA's Oncologic Drugs Advisory Committee voted yes to future approvals of PI3K inhibit…

View article →

Articles

Q&A: Landmark 10-Year Look at CAR T-Cell Outcomes in B-Cell Lymphomas

|
By Nichole Tucker Verified, Marco Ruella
| Blood Cancers Today Verified
In an interview with Blood Cancers Today, Marco Ruella, MD of the University of Pennsylvania’s Perelman School of Medicine, discusses the significance of these findings and what they mean for clinicians treating patients with B-cell lymphomas. Dr. Ruella also explores what the data reveal about CAR T-cell persistence, long-term surveillance for survivors, and the lingering questions that will guide the development of future cellular therapies. This transcript has been edited for clarity.
Open in Who Shared Issue with article?

What Fellows Want and the Turning Point in Training

|
By Nichole Tucker Verified
| Blood Cancers Today Verified
Fellowship programs are often highly structured and carefully designed to meet the evolving demands of oncology practice. Yet, as training priorities expand, one consideration has historically received less attention: not every fellow is preparing for the same career. For decades, oncology fellowships have reflected academic models of practice. But growing recognition is taking hold across graduate medical education.
Open in Who Shared Issue with article?

Q&A: Rethinking Treatment Priorities in Multiple Myeloma

|
By Nichole Tucker Verified
| Blood Cancers Today Verified
In an interview with Blood Cancers Today, Hira Mian, MD, MSc, of McMaster University, shares how these developments are influencing clinical practice, discusses where she believes the field is headed, and reflects on the questions that future clinical trials and real-world research will need to answer. Blood Cancers Today: Lately, your peers have been mentioning changes in their approach to caring for patients with multiple myeloma.
Open in Who Shared Issue with article?
See all 239 licensed articles (1,216 Total)